- 2025-04-12 17:34PF-431396 717906-29-1
- 2025-04-12 17:34Rebastinib (DCC2036) 1020172-07-9
- 2025-04-12 17:34Maribavir 176161-24-3
- 2025-04-12 17:34EBOV-IN-3 2896193-40-9
- 2025-04-12 17:34ALK/EGFR-IN-2 2730432-75-2
- 2025-04-12 17:34(5α)-Stigmastane-3,6-dione 22149-69-5
- 2025-04-12 17:34(2S,5S)-Censavudine ((2S,5S)-OBP-601; (2S,5S)-BMS-986001)
- 2025-04-12 17:343-Formyl rifamycin 13292-22-3
- 2025-04-12 17:34AMPK activator 13
- 2025-04-12 17:34Aflibercept (VEGF Trap; VEGF-TRAPR1R2; VEGF-trapR1) 862111-32-8
- 2025-04-12 17:34(Z)-Fluoxastrobin 887973-21-9
- 2025-04-12 17:34FZ-AD005
- 2025-04-12 17:34Antiproliferative agent-54 1240322-54-6
- 2025-04-12 17:34Methyl lucidenate L 110267-46-4
- 2025-04-12 17:33BTK-IN-36 2502301-31-5
- 2025-04-12 17:33Faldaprevir sodium 1215856-44-2
- 2025-04-12 17:33FLT3-IN-18 752191-77-8
- 2025-04-12 17:337-Hydroxyethyl carbamate-(10Me-11F-Camptothecin) 2873460-17-2
- 2025-04-12 17:33(2R,4S)-1-tert-Butyl 2-methyl 4-hydroxypyrrolidine-1,2-dicarboxylate 135042-17-0
- 2025-04-12 17:33Syk Inhibitor II hydrochloride 2490508-82-0
